Loading company…
Response BioMedical develops rapid point-of-care diagnostic testing systems.
Response BioMedical develops rapid, quantitative point-of-care tests, including its RAMP 200 system for cardiovascular and other biomarkers. The company is based in Vancouver, Canada, and serves hospitals, emergency care facilities, and laboratories. OrbiMed Advisors and Shanghai Runda Medical Technology Co.,Ltd. acquired it for CAD 1.3 million in June 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in